INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹241 Cr | ₹280 Cr | ₹23 Cr | ₹-44 Cr | ₹-30 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹241 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹-44 Cr |
| Mar2021 | ₹-30 Cr |
How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹241 Cr | -13.91 | |
| Mar2024 | ₹280 Cr | 1,129.76 | |
| Mar2023 | ₹23 Cr | Positive | |
| Mar2022 | ₹-44 Cr | Negative | |
| Mar2021 | ₹-30 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,908.1 Cr | -2.1% | -14% | -36.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -2.1% |
-14% |
-36.1% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses